The cost effectiveness of pharmacotherapies for smoking cessation: necessary but not sufficient?

Appl Health Econ Health Policy. 2003;2(2):76-8.

Authors

Marian Shanahan¹, Christopher Doran, Jennifer Gates, Anthony Shakeshaft, Richard P Mattick

Affiliation

¹ National Drug and Alcohol Research Centre (NDARC), University of New South Wales, Sydney, Australia.

PMID: 14619277

No abstract available

Publication types

Comparative Study

MeSH terms

Administration, Cutaneous
Australia / epidemiology
Bupropion / administration & dosage*
Bupropion / economics
Cost-Benefit Analysis
Decision Making
Drug Costs / statistics & numerical data
Health Services Needs and Demand / economics
Humans
Nicotine / administration & dosage*
Nicotine / economics
Patient Acceptance of Health Care*
Smoking / drug therapy*
Smoking / epidemiology
Smoking Cessation / economics*
Smoking Cessation / methods
Treatment Outcome

Substances

Bupropion
Nicotine